|
Post by mytakeonit on Apr 3, 2017 13:50:47 GMT -5
There you go mytakeonit :-) Now we better soon have a 1,000 script Friday! I don't know sports ... maybe you should go back to the original pic. Last night I was having nightmares of you asking me ... "Did you drink my drink?!!"
|
|
|
Post by peppy on Apr 3, 2017 14:44:29 GMT -5
|
|
|
Post by mytakeonit on Apr 3, 2017 15:40:55 GMT -5
All aboard !!! Sports runaway "Big Hair" train is now leaving the station ...
|
|
|
Post by sportsrancho on Apr 3, 2017 16:16:03 GMT -5
All aboard !!! Sports runaway "Big Hair" train is now leaving the station ... I'd like to see your hair, or your face :-)
|
|
|
Post by saxcmann on Apr 3, 2017 16:34:51 GMT -5
I would take 300 scripts this Friday.
|
|
|
Post by MnkdWASmyRtrmntPlan on Apr 3, 2017 16:57:56 GMT -5
I would take 300 scripts this Friday. I'm with you, Sax. 300 would be nice.
|
|
|
Post by Actual Investor on Apr 3, 2017 17:06:16 GMT -5
Peppy,
I think I went to High School with #5 from the left in the first row. That was "Standard of Hair" in 1963!
|
|
|
Post by mytakeonit on Apr 3, 2017 17:53:32 GMT -5
All aboard !!! Sports runaway "Big Hair" train is now leaving the station ... I'd like to see your hair, or your face :-) Here you go Sports. Seems that we selected this room to do this Big Hair discussion ... because we are really kids at heart. BTW, I'm a secret agent and also a celebrity ... as you can tell from my pic ... so keep it under wraps and not tell anyone. Shhh ...
|
|
|
Post by goyocafe on Apr 16, 2017 23:09:20 GMT -5
Bringing this thread forward again. Wasn't this supposed to start last month? What are they waiting for?
|
|
|
Post by Cowgirl on Apr 16, 2017 23:33:45 GMT -5
They have no money for this or for the longer term safety study. While required by the FDA if they are not around then ...not required. While they've fed excuses as to delay, negotiating with FDA ,it falls into the category of the commercials as well....more of a lot of nothing out of mannkind. They are hoping someone will buy em as the price gets cheaper and cheaper but as a buyer sees sales in the hundreds of scripts - and the liability of the long term trial and the pediatric trial - even $150 Million is too much. All of Al Mann's money is gone and those clipping large paychecks will keep the lights on as long as they can under the premise of giving it a "good college try". Embarrassing.
|
|
|
Post by dearlew9 on Apr 16, 2017 23:41:23 GMT -5
They have no money for this or for the longer term safety study. While required by the FDA if they are not around then ...not required. While they've fed excuses as to delay, negotiating with FDA ,it falls into the category of the commercials as well....more of a lot of nothing out of mannkind. They are hoping someone will buy em as the price gets cheaper and cheaper but as a buyer sees sales in the hundreds of scripts - and the liability of the long term trial and the pediatric trial - even $150 Million is too much. All of Al Mann's money is gone and those clipping large paychecks will keep the lights on as long as they can under the premise of giving it a "good college try". Embarrassing. How dare you speak alternative facts? FUDster?
|
|
|
Post by dreamboatcruise on Apr 17, 2017 3:23:33 GMT -5
They have no money for this or for the longer term safety study. While required by the FDA if they are not around then ...not required. While they've fed excuses as to delay, negotiating with FDA ,it falls into the category of the commercials as well....more of a lot of nothing out of mannkind. They are hoping someone will buy em as the price gets cheaper and cheaper but as a buyer sees sales in the hundreds of scripts - and the liability of the long term trial and the pediatric trial - even $150 Million is too much. All of Al Mann's money is gone and those clipping large paychecks will keep the lights on as long as they can under the premise of giving it a "good college try". Embarrassing. Ouch. You're kinda negative. But I like the fact you make me seem positive
|
|
|
Post by cjm18 on Apr 17, 2017 9:36:24 GMT -5
They have no money for this or for the longer term safety study. While required by the FDA if they are not around then ...not required. While they've fed excuses as to delay, negotiating with FDA ,it falls into the category of the commercials as well....more of a lot of nothing out of mannkind. They are hoping someone will buy em as the price gets cheaper and cheaper but as a buyer sees sales in the hundreds of scripts - and the liability of the long term trial and the pediatric trial - even $150 Million is too much. All of Al Mann's money is gone and those clipping large paychecks will keep the lights on as long as they can under the premise of giving it a "good college try". Embarrassing. Ouch. You're kinda negative. But I like the fact you make me seem positive [ If things are that bad why are they spending 10m a month? 150 employees at 125 k per year is only like 16% of the burn rate.
|
|
|
Post by silentknight on Apr 17, 2017 10:03:59 GMT -5
Ouch. You're kinda negative. But I like the fact you make me seem positive [ If things are that bad why are they spending 10m a month? 150 employees at 125 k per year is only like 16% of the burn rate. I think they're spending 120 million a year in an effort to sell Afrezza under what they deem to be the most effective way to achieve results. Obviously, everyone knows their plan isn't working. Script numbers can't break 300 per week despite MNKD's best efforts and the daily sell off drives the stock closer and closer to another delisting scenario every day that it trades. People who believe this company is going to be bought out are deluding themselves. Their only approved product has been demonstrated to be a commercial bust on two occasions now, their R&D pipeline is years away from becoming an actual marketable product, and the potential marketability of said R&D candidates has been seriously called into question due to Afrezza's inability to become commercially viable. The only material events we're likely to see in the coming months are dilution or bankruptcy in my opinion. We were all duped into believing that Afrezza's efficacy directly translates to marketability. All of us longs were wrong. I can admit that now and sadly, Al Mann was wrong too. He was at least in the sense that he believed Afrezza would be the success he thought it would be. The drug works wonderfully, but there's no successful market for it here. Kids may be there but I have serious doubts about MNKD's ability to see the trials through to approval. The company will offer up the same tiresome excuses at the shareholder meeting and quarterly updates that we've heard for years now. Same old song and dance with nothing to show for it. Please, all I want for Christmas is for MNKD to sell the damned drug....
|
|
|
Post by silentknight on Apr 17, 2017 10:43:18 GMT -5
kbrion77 "Seriously state facts to disprove this statement." That proposition requires everyone to agree with that statement. If I disagree, the proposition is false. Try reading basic logic, you need it. Ok, I'll re-phrase the statement. "Obviously, anyone who takes a rational and un-biased look at the facts will realize that their plan isn't working". If you can refute the statement using evidence of a market turnaround, I'd love to hear it. The weekly script numbers have been at their current level for months now, despite MNKD's efforts. That would indicate, to a rational person, that their efforts have, in fact, been ineffective. Most won't believe me, but that's actually not a knock on the company. I think they're trying their best. The problem is that their best isn't good enough. Of course that could improve in the future, but they've proven themselves to be of little consequence thus far.
|
|